SYROS PHARMACEUTICALS, INC. Operating Lease, Payments
SYROS PHARMACEUTICALS, INC. reported Operating Lease, Payments of $1.04 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2024-05-14
- SYROS PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2024-03-31 was $1.04M, a 2.98% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2023-12-31 was $1.03M, a 2.91% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2023-09-30 was $1.01M, a 2.86% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, payments for the quarter ending 2023-06-30 was $1.01M, a 2.86% increase year-over-year.
- SYROS PHARMACEUTICALS, INC. operating lease, payments for fiscal 2023 was $4.05M, a 2.87% increase from fiscal 2022.
- SYROS PHARMACEUTICALS, INC. operating lease, payments for fiscal 2022 was $3.94M, a 2.93% increase from fiscal 2021.
- SYROS PHARMACEUTICALS, INC. operating lease, payments for fiscal 2021 was $3.82M, a 22.45% increase from fiscal 2020.
- SYROS PHARMACEUTICALS, INC. operating lease, payments for fiscal 2020 was $3.12M, a 131.95% increase from fiscal 2019.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.04M 10-Q · filed 2024-05-14 | $2.06M derived: sum of 2 quarters · filed 2024-05-14 | $3.07M derived: sum of 3 quarters · filed 2024-05-14 | $4.08M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.03M derived: sum of 2 quarters · filed 2024-03-27 | $3.04M derived: sum of 3 quarters · filed 2024-03-27 | $4.05M 10-K · filed 2024-03-27 |
| 2023-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.01M derived: sum of 2 quarters · filed 2023-11-14 | $3.02M 10-Q · filed 2023-11-14 | $4.02M derived: sum of 4 quarters · filed 2023-11-14 |
| 2023-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.01M 10-Q · filed 2023-08-08 | $3.01M derived: sum of 3 quarters · filed 2023-08-08 | $3.99M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | $1.01M 10-Q · filed 2023-05-10 | $2.00M derived: sum of 2 quarters · filed 2023-05-10 | $2.98M derived: sum of 3 quarters · filed 2023-05-10 | $3.96M derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | $998.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $1.98M derived: sum of 2 quarters · filed 2023-03-02 | $2.96M derived: sum of 3 quarters · filed 2023-03-02 | $3.94M 10-K · filed 2023-03-02 |
| 2022-09-30 | $979.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.96M derived: sum of 2 quarters · filed 2022-11-14 | $2.94M 10-Q · filed 2022-11-14 | $3.91M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $979.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.96M 10-Q · filed 2022-08-09 | $2.93M derived: sum of 3 quarters · filed 2022-08-09 | $3.88M derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | $979.00K 10-Q · filed 2022-05-16 | $1.95M derived: sum of 2 quarters · filed 2022-05-16 | $2.90M derived: sum of 3 quarters · filed 2022-05-16 | $3.85M derived: sum of 4 quarters · filed 2022-05-16 |
| 2021-12-31 | $970.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.92M derived: sum of 2 quarters · filed 2022-03-15 | $2.87M derived: sum of 3 quarters · filed 2022-03-15 | $3.82M 10-K · filed 2022-03-15 |
| 2021-09-30 | $951.00K 10-Q · filed 2021-11-05 | $1.90M derived: sum of 2 quarters · filed 2021-11-05 | $2.85M 10-Q · filed 2021-11-05 | $3.80M derived: sum of 4 quarters · filed 2021-11-05 |
| 2021-06-30 | $951.00K 10-Q · filed 2021-08-05 | $1.90M 10-Q · filed 2021-08-05 | $2.85M derived: sum of 3 quarters · filed 2021-08-05 | $3.77M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | $951.00K 10-Q · filed 2021-05-06 | $1.89M derived: sum of 2 quarters · filed 2021-05-06 | $2.82M derived: sum of 3 quarters · filed 2021-05-06 | $3.74M derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | $943.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $1.87M derived: sum of 2 quarters · filed 2021-03-04 | $2.79M derived: sum of 3 quarters · filed 2021-03-04 | $3.12M 10-K · filed 2021-03-04 |
| 2020-09-30 | $925.00K 10-Q · filed 2020-11-05 | $1.85M derived: sum of 2 quarters · filed 2020-11-05 | $2.18M 10-Q · filed 2020-11-05 | $2.92M derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | $925.00K 10-Q · filed 2020-08-06 | $1.25M 10-Q · filed 2020-08-06 | $2.00M derived: sum of 3 quarters · filed 2020-08-06 | $2.33M derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | $714.00K 10-Q · filed 2020-05-07 | $1.07M derived: sum of 2 quarters · filed 2020-05-07 | $1.40M derived: sum of 3 quarters · filed 2020-05-07 | $1.73M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | $357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05 | $687.00K derived: sum of 2 quarters · filed 2020-03-05 | $1.02M derived: sum of 3 quarters · filed 2020-03-05 | $1.35M 10-K · filed 2020-03-05 |
| 2019-09-30 | $330.00K 10-Q · filed 2019-11-12 | $660.00K derived: sum of 2 quarters · filed 2019-11-12 | $989.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $330.00K 10-Q · filed 2019-08-01 | $659.00K 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $330.00K 10-Q · filed 2019-05-01 |